68 results
424B3
PRTG
Portage Biotech Inc
12 Apr 24
Prospectus supplement
5:22pm
using innovative trial designs and translational data to identify the patient populations most likely to benefit from treatment. For more information
6-K
EX-99.1
PRTG
Portage Biotech Inc
12 Apr 24
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
5:21pm
are being advanced using innovative trial designs and translational data to identify the patient populations most likely to benefit from treatment. For more
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
2A inhibitor) and PORT-7 (adenosine 2B inhibitor). These programs are being advanced using innovative trial designs and translational data to identify
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
is to advance and grow a portfolio of innovative, early-stage oncology assets based on the latest scientific breakthroughs focused on overcoming immune
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
scientific rationales.
The Portage Approach
Our mission is to advance and grow a portfolio of innovative, early-stage oncology assets based
424B3
mo1h6ps
4 Jan 24
Prospectus supplement
5:49pm
6-K
EX-99.1
w9d0ip
4 Jan 24
Current report (foreign)
8:10am
424B3
fnqy 89f5
28 Nov 23
Prospectus supplement
4:03pm
6-K
EX-99.1
1q9lip ak5t
28 Nov 23
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
4:02pm
6-K
EX-99.2
w6mgeh79 db1ug
28 Nov 23
Current report (foreign)
4:01pm
424B3
8gy5 ez8uurcpw84x6
7 Nov 23
Prospectus supplement
4:50pm
F-1
sqzpk cyvi3
31 Oct 23
Registration statement (foreign)
4:05pm
424B5
r8i65rbv
2 Oct 23
Prospectus supplement for primary offering
6:01pm
6-K
EX-99.1
msyijgu2oinu1fi
29 Sep 23
Portage Biotech Announces $6.0 Million Registered Direct Offering
8:01am
6-K
EX-99.1
bbjb0hqkf0m5 m57o
30 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.2
mbndd76e3
29 Aug 23
Current report (foreign)
4:01pm
6-K
EX-99.1
acotq ymkvwgqvc6
31 Jul 23
Current report (foreign)
6:10pm
6-K
EX-99.1
by0htabrvgr98rso
30 Nov 22
Current report (foreign)
9:08pm
6-K
EX-99.2
swp5vk4 y6h4
29 Nov 22
Current report (foreign)
4:58pm